top of page

Manufacturing and Developing Psychedelic Medicines to Unlock Neurologic Potential

Screenshot 2022-05-14 210349_edited.png

Precision Fermentation

Scalable, sustainable, and economic manufacturing of psychedelic molecules


Focused on commercially significant and overlooked unmet needs


Intellectual Property

Large intellectual property portfolio underpins accelerated timelines to market


Partnered with Australia's most dynamic institutions, advisors and industry partners  

We are focused on commercially significant opportunities

US$7 Billion
Psychedelic molecule production market by 2026
Of children have neurodevelopmental disorders
$68 Billion
Global neuro-degenerative disease market by 2027

Acknowledgement of Country 

We acknowledgesthe Traditional Owners of the unceded land where we work and live. We pay our respects to Elders past, present and emerging. We celebrate the stories, culture and traditions of Aboriginal and Torres Strait Islanders of all communities who work and live on this land


Send us a message
and we’ll get back to you shortly.

Thanks for submitting!

bottom of page